ARCHIVES

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 13 | April 4, 2008

Download PDF Visit The Full Archive

Related Articles

Cancer Advocacy: March On Washington Scheduled For September 1998

October 31, 1997

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

June 27, 2014

RFAs Available

February 23, 1996

Monoclonal Antibody Improves AML Response To Therapy

July 26, 2002

In Brief: House Appropriations Bill Marked Up, Lid Clamped On; Wells Named DCT Board Chairman

July 6, 1984

Center And Cooperative Group Clinical Trials Approved By NCI

May 27, 2005